Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-19

FDA Approved: SEVELAMER CARBONATE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Macleods Pharmaceuticals Limited's sevelamer carbonate as an original-application generic for treating hyperphosphatemia in patients with chronic k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)